The massive growth of the CBD-based product market continues to be one of the most active opportunities in the multi-billion dollar legal marijuana/cannabis markets, as experts are currently forecasting the CBD segment alone to grow to $2.1 Billion by 2020, according to The Hemp Business Journal. Through innovation and the development of new product lines with new uses, aggressive companies in the space are tapping into new consumer markets to increase their market share. CBD-based products have a growing list of uses with the potential to be used in a number of ways, ranging from therapeutic benefits, consumer edible products, health and wellness products and even animal/pet medications. CBD applications and uses are nonpsychoactive and are known for targeting reliefs
News Video about CBD In the News- First CBD retail store opens in Las Vegas
Cannabis has been vilified and attacked for nearly a century by industry propaganda, ignorant beliefs and controlling government dictates. As more people learn what cannabis is and all that it entails, they can release their feelings of dissension, control, judgment and paranoia toward the plant and those who use it.
As cannabis knowledge spreads, hemp, marijuana and CBDs are finally getting the recognition they deserve as powerful vessels of healing. The most popularly bred component of marijuana, tetrahydrocannabinol (THC), can be used for recreational purposes, to reduce pain, relieve stress and excite pleasure in the mind. There are other non-psychoactive components of cannabis that can be extracted and used for medicinal purposes too.
Other compounds that have entered the research spotlight include: Cannabidiol (CBD), Cannabinol (CBN), Cannabichromene (CBC), Cannabigerol (CBG) and Tetrahydrocannabivarin (THCV).
As reported by Natural Blaze, some of the health problems that cannabis oil helps include: epilepsy, neuromuscular disorders, glaucoma, muscular schlerosis, Tourette’s, amyotrophic lateral sclerosis (ALS) and chronic pain.
The many components of medicinal cannabis oil
When people speak of medicinal cannabis, they are referring to the compounds that are found in the resin of the leaves, flowers and roots of the plant. Cannabis leaves and flowers are covered in trichomes, which are small glands of resinous oil. This resinous oil differs from strain to strain, and contains different ratios of cannabinoids, as well as over a hundred kinds of biologically active and aromatic terpenes.
Cannabis is simply a flowering plant with fibrous stalks, and these stalks (hemp) can be used to make paper, rope, clothing and other building materials. Its seeds are an excellent food source that is full of healthy oils and fats for internal and external use. Hemp seed oil is growing in popularity for use in cosmetic products.
Breeders now develop a strain of cannabis that is dominant in CBD. This strain is used to treat anxiety, nausea, convulsions and inflammation without any intoxicating effects.
Beyond these wonderful properties, cannabis also contains a powerful surplus of flavonoids, terpenes and other biologically active compounds that help the body heal.
CBD oil is starting to build a positive reputation, unlike its other relative, THC, which is also cannabinoid in cannabis just like CBD but provides psychoactive effects. Thus, more and more people, including researchers and healthcare providers, discovered that CBD is entirely safe to use, by both adults and children, because it does not make you high. But, the main reason behind this increasing popularity is the fact that CBD has a wide range of benefits when it comes to health. So, how to use CBD Oil?
While some may use it pretty much in the same manner as regular supplements, especially for managing stress, anxiety and high-pressure situations, many people use CBD oil to control symptoms that are hard to bear of severe illnesses.
Many studies and researchers discovered, in the past years, that CBD can be extremely useful if consumed as a supplement or alternative treatment for a variety of illnesses. These scientific finds, backed up by testimonials of people that decided to try CBD as treatment and obtained positive results, led to the increase of CBD’s popularity. But, the federal government didn’t see cannabidiol with such good eyes, doing its best to include CBD in the Schedule I Controlled Substance’s group since last year.
Apparently, the feds cannot ignore the results provided by CBD in the medical world and the increasingly higher number of people that enjoy improved life quality due to this component, finally admitting that CBD can be “beneficial”.
Non-psychoactive and beneficial
It is well-known the fact that CBD has no psychoactive effects producing positive effects on patients suffering from neurological disorders without the “high” effect known among cannabis users. So, many people wonder, if CBD is not a psychoactive component and brings health benefits, why this reticence of using it widely exists on the side of the authorities?
The answer lies in the fact that there are still very many superstitions and wrong assumptions when it comes to CBD because it is extracted from cannabis, known for so many decades as a psychoactive plant. But, every laboratory test done on CBD proved, without a doubt, that CBD does not provide such effects on whoever decides to consume it or use it as treatment.
At least six states started industrial hemp programs, pushing the total number of hemp states to the mid-30s.
Hemp’s growth wasn’t limited to the United States. Canada’s hemp growers learned in November that they’ll soon be allowed to process hemp flower for CBD – a decision that will unleash a huge new market opportunity.
And in Europe, hemp-derived cannabidiol products exploded alongside smokable hemp products.
The hemp boom can be explained in three easy letters – CBD. Agronomists report that hemp rich in cannabidiol can produce as much profit as an acre of corn. High-CBD flower is selling for more than $100 a pound.
And CBD products are sold in many states where medical marijuana is not. The World Anti-Doping Agency announced in September that it would remove CBD from the list of substances banned at the Olympics and other international sporting competitions. And the UN’s health agency, the Switzerland-based World Health Organization, said in December that CBD should not be a scheduled drug.
Markets are responding. Cannabis research firm Brightfield Group estimated that the U.S. market for hemp-derived CBD market hit $291 million in 2017 and will balloon to $1.65 billion by 2021 – an increase topping 500% in just four years.
A World Health Organization (WHO) report has found no adverse health outcomes but rather several medical applications for cannabidiol, a.k.a. CBD, despite U.S. federal policy on this cannabinoid chemical.
According to a preliminary WHO report published last month, naturally occurring CBD is safe and well tolerated in humans (and animals), and is not associated with any negative public health effects.
Experts further stated that CBD, a non-psychoactive chemical found in cannabis, does not induce physical dependence and is “not associated with abuse potential.” The WHO also wrote that, unlike THC, people aren’t getting high off of CBD, either.